Return to Previous Page
Details
The N-terminal Aβ fragments Aβ1-14, Aβ1-15, and Aβ1-16 are elevated in cell media and in CSF in response to γ-secretase inhibitor treatment. The presence of these small peptides is consistent with a catabolic amyloid precursor protein cleavage pathway by β- followed by α-secretase. It has been shown that Aβ1-14, Aβ1-15, and Aβ1-16 increase dose-dependently in response to γ-secretase inhibitor treatment while Aβ1-42 levels are unchanged.
Catalog Number
H-7372
One Letter Code
DAEFRHDSGYEVHH
Molecular Formula
C₇₃H₉₉N₂₃O₂₅
Relative Molecular Mass
1698.73
CAS Registry Number
186319-74-4
Source
Synthetic
Storage Conditions
-20 ± 5 °C
Keywords
Biomarker
Application
Alzheimer's Disease
Links / Documents:
